AzTrials
AzTrials

Prevention of Diabetic FootBIONEDIANNCT04257409

Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects

A study testing Physical intervention by exercise in people with Prevention of Diabetic Foot, run by Mgr. Eliška Vrátná at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in… Read more about this study

Who is it for?
Ages 30 to 75 years
Conditions the study is for
Prevention of Diabetic Foot
What is being tested?
Physical intervention by exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteCzechia
Study dates
1 Jan 2019to 1 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Type 2 diabetes mellitus
  • sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results)
  • diabetic foot with healed diabetic foot ulcers, inactive Charcot foot

Who cannot join

  • impossibility to exercise
  • amaurosis
  • non-compliance
  • critical limb ischemia
  • active ulcer, surgical wound
  • active Charcot foot
Show all 13Show fewer
  • active carcinoma
  • recent stroke (last 8 weeks)
  • recent myocardial infarction (last 8 weeks)
  • recent PTA, PCI, bypass (last 8 weeks)
  • myopathy
  • rheumatoid arthritis
  • cox-, gonartrosis of 3rd -4th grade.

Trial locations and contacts

1 site in 1 country.

Eliška Vrátná, Mgr. contact

+420774549214

vratnae@gmail.com

Vladimíra Fejfarová, MD, PhD contact

+420603877381

vlfe@medicon.cz

Czechia1 site, 1 recruiting
  • Institute for Clinical and Experimental Medicine

    Prague, 14200

    Eliška Vrátná, Mgr., +420774549214, vratnae@gmail.com

    Vladimíra Fejfarová, MD, PhD, +420603877381, vlfe@medicon.cz

    Recruiting

Other trials in Czechia

About this study

Official title: Musculoskeletal Changes Induced by Physiotherapeutic Intervention, and Their Impact on the Induction of Diabetic Foot Syndrome and Psychosocial Status in Type 2 Diabetes Mellitus

The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with different degrees of neuropathy. During this project, investigators will examine the possible impact of 12-week lasting intervention program on the distribution of plantar pressures, joint mobility and muscle strength of lower limbs. The incidence of ulcerations / reulcerations and changes of psychosocial characteristics will be evaluated during the study period.

Approximately 60 patients with Type 2 diabetes mellitus will be included into the study. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.

The outcomes of this project will try to objectively verify in the randomized controlled trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot syndrome.

Being tested
Physical intervention by exercise
Keywords
diabetic foot, biomechanics, quality of life, prevention
Medical subject headings
Diabetic Foot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical intervention by exerciseOther

    12 week lasting exercise intervention

Study groups in NCT04257409
Study groupRoleWhat they receive
DF patient activeExperimentalPatients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
Receives: Other: Physical intervention by exercise
DF patient controlActive comparatorPatients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
Receives: Other: Physical intervention by exercise
Diabetic patient with mild neuropathyExperimentalPatients with Type 2 diabetes mellitus with mild form of peripheral sensory neuropathy
Receives: Other: Physical intervention by exercise
Diabetic patient with severe neuropathyExperimentalPatients with Type 2 diabetes mellitus with severe form of peripheral sensory neuropathy
Receives: Other: Physical intervention by exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Biomechanics- plantar pressures

    plantar pressures will be evaluated by pedobarograph (in Newtons)

    Measured: changes after 12 weeks, 24 weeks

  2. Biomechanics- biomechanics of the ankle

    biomechanics of the ankle will be assessed by goniometry in angles

    Measured: changes after 12 weeks, 24 weeks

  3. Biomechanics- changes of foot joint angles

    changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle

    Measured: changes after 12 weeks, 24 weeks

  4. Fitness - physical activity

    The amount of physical activity will be assessed by IPAQ questioners

    Measured: changes after 12 weeks, 24 weeks

  5. Fitness - muscle strength

    Muscle strength will be measured by dynamometry in Newtons

    Measured: changes after 12 weeks, 24 weeks

  6. Fitness - senior fitness

    fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)

    Measured: changes after 12 weeks, 24 weeks

Secondary outcomes (7)
  1. ulceration/reulceration

    detection of the incidence of ulceration/reulceration

    Measured: changes after 12 weeks, 24 weeks

  2. Psychosocial changes - quality of life

    Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings

    Measured: changes after 12 weeks, 24 weeks

  3. Psychosocial changes - depression

    Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression

    Measured: changes after 12 weeks, 24 weeks

  4. Psychosocial changes - stress readaptation

    Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation

    Measured: changes after 12 weeks, 24 weeks

  5. Metabolism - glucose control

    Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)

    Measured: changes after 12 weeks, 24 weeks

  6. Metabolism - lipid profile

    The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)

    Measured: changes after 12 weeks, 24 weeks

  7. Metabolism - myokines

    Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)

    Measured: changes after 12 weeks, 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2020
  2. Study start1 Jan 2019
  3. Primary completion30 Mar 2020 (estimated)
  4. Study completion1 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
60 patients with Type 2 diabetes mellitus. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04257409
Sponsor's protocol ID
546417
Acronym
BIONEDIAN
Status last verified
Feb 2020
First submitted
15 Dec 2019
Last updated
6 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Possible to look at the data in documentation site

Questions about this trial

What is this clinical trial studying?

A study testing Physical intervention by exercise in people with Prevention of Diabetic Foot, run by Mgr. Eliška Vrátná at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eliška Vrátná, Mgr. (+420774549214, vratnae@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Biomechanics- plantar pressures (time frame: changes after 12 weeks, 24 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in